Xiaochong Deng

685 total citations
19 papers, 431 citations indexed

About

Xiaochong Deng is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Xiaochong Deng has authored 19 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Cell Biology. Recurrent topics in Xiaochong Deng's work include Circular RNAs in diseases (7 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (7 papers). Xiaochong Deng is often cited by papers focused on Circular RNAs in diseases (7 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (7 papers). Xiaochong Deng collaborates with scholars based in China, Australia and United States. Xiaochong Deng's co-authors include Lin Fang, Changle Ji, Lin Fang, Xuehui Wang, Kaiyao Hua, Yunhe Yu, Wenfang Zheng, Jiashu Hu, Hongming Song and Qifeng Luo and has published in prestigious journals such as Cancer Letters, The International Journal of Biochemistry & Cell Biology and Cell Death and Disease.

In The Last Decade

Xiaochong Deng

19 papers receiving 426 citations

Peers

Xiaochong Deng

ONCOL

PRM

Changle Ji China

Weifan Xiao China

Laura A. Link United States

Yulei Du China

Junjie Qu China

Woo Chan Shin South Korea

Zeng-Quan Yang United States

Jinsong Liu United States

Xinhua Xie China

Hao-Rong Wu China

Changle Ji China

Xiaochong Deng

378 ×1.1

295 ×1.3

52 ×0.6

61 ×1.1

ONCOL

37 ×1.4

PRM

Citations per year, relative to Xiaochong Deng Xiaochong Deng (= 1×) peers Changle Ji

Countries citing papers authored by Xiaochong Deng

Since Specialization

Citations

This map shows the geographic impact of Xiaochong Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochong Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochong Deng more than expected).

Fields of papers citing papers by Xiaochong Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaochong Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochong Deng. The network helps show where Xiaochong Deng may publish in the future.

Co-authorship network of co-authors of Xiaochong Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaochong Deng. A scholar is included among the top collaborators of Xiaochong Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaochong Deng. Xiaochong Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Wang, Xuehui, et al.. (2024). K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer. Cancer Letters. 588. 216764–216764. 5 indexed citations

Wang, Xuehui, et al.. (2024). DLAT promotes triple-negative breast cancer progression via YAP1 activation. Cancer Biology & Therapy. 25(1). 2421578–2421578. 2 indexed citations

Wang, Zhongrui, Xiaochong Deng, Wenfang Zheng, et al.. (2023). miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer. Frontiers in Oncology. 13. 1166666–1166666. 4 indexed citations

Wang, Yuying, et al.. (2023). DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP. Cell Death and Disease. 14(2). 106–106. 14 indexed citations

Deng, Xiaochong, et al.. (2023). E2F1-mediated ectopic expression of PP1A promotes breast cancer progression via activation of YAP1. The International Journal of Biochemistry & Cell Biology. 157. 106389–106389. 4 indexed citations

Yu, Yunhe, Wenfang Zheng, Changle Ji, et al.. (2022). Tumor-Derived circRNAs as Circulating Biomarkers for Breast Cancer. Frontiers in Pharmacology. 13. 811856–811856. 15 indexed citations

Luo, Qifeng, Wenfang Zheng, Xiaochong Deng, et al.. (2022). Circular RNA_0006014 promotes breast cancer progression through sponging miR-885-3p to regulate NTRK2 and PIK3/AKT pathway. Aging. 14(7). 3105–3128. 18 indexed citations

Wang, Xuehui, Changle Ji, Jiashu Hu, et al.. (2021). Hsa_circ_0005273 facilitates breast cancer tumorigenesis by regulating YAP1-hippo signaling pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 29–29. 57 indexed citations

Deng, Xiaochong, Changle Ji, Xuehui Wang, et al.. (2021). KIF23 promotes triple negative breast cancer through activating epithelial-mesenchymal transition. Gland Surgery. 10(6). 1941–1950. 27 indexed citations

10.

Deng, Xiaochong, Kaiyao Hua, Hongming Song, et al.. (2021). MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor. Cell Death and Disease. 12(9). 810–810. 17 indexed citations

11.

Huang, Yixiang, Wenfang Zheng, Changle Ji, et al.. (2021). Circular RNA circRPPH1 promotes breast cancer progression via circRPPH1-miR-512-5p-STAT1 axis. Cell Death Discovery. 7(1). 376–376. 22 indexed citations

12.

Ji, Changle, Jiashu Hu, Xuehui Wang, et al.. (2021). Hsa_circ_0053063 inhibits breast cancer cell proliferation via hsa_circ_0053063/hsa-miR-330-3p/PDCD4 axis. Aging. 13(7). 9627–9645. 17 indexed citations

13.

Wang, Xuehui, Changle Ji, Wenfang Zheng, et al.. (2021). The Role of miR-640: A Potential Suppressor in Breast Cancer via Wnt7b/β-catenin Signaling Pathway. Frontiers in Oncology. 11. 13 indexed citations

14.

Hua, Kaiyao, Xiaochong Deng, Jiashu Hu, et al.. (2020). Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer. Journal of Experimental & Clinical Cancer Research. 39(1). 58–58. 42 indexed citations

15.

Luo, Qifeng, Hongming Song, Xiaochong Deng, et al.. (2020). A Triple-Regulated Oncolytic Adenovirus Carrying MicroRNA-143 Exhibits Potent Antitumor Efficacy in Colorectal Cancer. Molecular Therapy — Oncolytics. 16. 219–229. 19 indexed citations

16.

Hu, Jiashu, Changle Ji, Kaiyao Hua, et al.. (2020). Hsa_circ_0091074 regulates TAZ expression via microRNA‑1297 in triple negative breast cancer cells. International Journal of Oncology. 56(5). 1314–1326. 22 indexed citations

17.

Song, Hongming, Qifeng Luo, Xiaochong Deng, et al.. (2019). VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer. Experimental & Molecular Medicine. 51(11). 1–13. 35 indexed citations

18.

Deng, Xiaochong & Lin Fang. (2018). VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.. PubMed. 8(6). 932–943. 58 indexed citations

19.

Song, Hongming, Dengfeng Li, Tianqi Wu, et al.. (2018). MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD. BMB Reports. 51(11). 602–607. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact